Estee Lauder Companies Inc (EL)
Consumer StaplesHousehold & Personal ProductsFairly valued
Price: $111.75 · Nov 13, 2026Analysis of Nov 10, 2026
Fair value
- Fair value · Low
- $92.69
- Fair value · Mid
- $115.87
- Fair value · High
- $139.04
Scorecard
Five subjects rated by the server with fixed thresholds. No overall grade: each colour shows where the strength or the weakness is.
Altman zone: Grey (Z 2.9) · annual report of Jun 30, 2026
Fairly valued
Analysis
Conclusion
Estée Lauder Companies Inc sells skin care, makeup, fragrance and hair care under brands including La Mer, Estée Lauder, Clinique, M·A·C and Jo Malone London. At 113.16 USD on 2026-11-09, its market capitalisation is 28.0 billion USD and its enterprise value is 34.0 billion USD.
The verdict is fair. Today's P/E of 76.2 is above its ten-year median of 46.0, but EV/EBITDA of 18.2 is below its median of 25.4, and P/FCF of 18.5 is below its median of 41.2. The DCF gives 60.72 USD per share at a discount rate of 11.05%, while the fair value from historical multiples is 171.02 USD. The fair value band runs from 92.69 to 139.04 USD with a midpoint of 115.87 USD, giving a margin of safety of 2.4%. The reverse DCF implies revenue growth of 11.6% a year, against a five-year revenue CAGR of -1.5% and a five-year free cash flow per share CAGR of -15.0%.
What holds the case up is cash generation: free cash flow conversion of 412.2% on a trailing basis, a Piotroski score of 7 out of 9, and eight beats in eight quarters. What would break it is returns below the cost of capital, with ROIC of 7.0% against a WACC of 9.1%, net debt to EBITDA of 3.2, and revenue that has declined over five years.
Financial health
Financial strength is yellow: the current ratio of 1.25 is good, while net debt to EBITDA of 3.2 and interest coverage of 3.3 are both on watch. The quick ratio is 0.82 and debt to equity is 2.28. The Altman Z-score is 2.90, in the grey zone. The Altman model was designed for manufacturers, so this reading is indicative only for a branded consumer goods company. Insolvency risk: low, about 1.6% by the estimate of the Ohlson model over one to two years. Debt is the main constraint on the company's financial flexibility.
Earnings quality
Earnings quality is green, with all three assessed signals rated good. Free cash flow conversion is 412.2% on a trailing basis and 136.5% over five years, and the accrual ratio is -8.0%, so cash flow exceeds reported earnings. Stock-based compensation is 1.9% of revenue, and free cash flow after it is 1.23 billion USD. The share count has fallen at a five-year compound rate of -0.2%. The Piotroski score is 7 out of 9, and the Beneish M-score is not available. The company beat estimates in all 8 of the last quarters, with an average surprise of 49.7%. Current-year estimates rose 7.5% over 90 days, with 7 upward and 5 downward revisions in the last 30 days. Next year's EPS estimate implies growth of 18.5%.
Profitability
Profitability is yellow. ROIC of 7.0% sits below the WACC of 9.1%, a gap of -2.1% in the company's own measure, so the business is not currently earning its cost of capital. Its five-year median ROIC is 6.4%. Gross margin of 76.0% is close to its ten-year median of 75.6%. Operating margin of 11.9% compares with a median of 12.8%, and net margin of 2.4% compares with a median of 7.2%. Operating margin stability is 37.5%. The DuPont split shows a net margin of 1.2%, an asset turnover of 0.76 and an equity multiplier of 5.19. Return on equity of 9.1% therefore relies heavily on leverage.
Growth
Growth is red. Revenue compound growth is -1.8% over three years, -1.5% over five years and 2.9% over ten years, and revenue grew in 6 of the 10 comparable years. EPS compound growth is -43.6% over three years, -42.3% over five years and -16.3% over ten years. The only positive signal is the next-year EPS estimate, which implies growth of 18.5%. That forecast is a sharp reversal from the recent record and depends on a turnaround that the reported figures do not yet show.
Valuation
Valuation is yellow, with one neutral signal. Against their ten-year medians, the P/E of 76.2 is a premium of 65.8%, while EV/EBITDA of 18.2 is a discount of 28.3%, P/FCF of 18.5 a discount of 55.1%, P/S of 1.8 a discount of 49.6% and P/B of 6.9 a discount of 33.8%. The DCF gives 60.72 USD per share at a discount rate of 11.05%, and 45.2% of its value sits in the terminal value. The reverse DCF implies 11.6% growth, against revenue growth of -1.5% and free cash flow per share growth of -15.0% over five years. The fair value band is built on fixed assumptions, not a price target. The dividend yield is 1.8%, the forward yield 1.3%, and the payout on free cash flow 33.4%.
Risks
The main risk is the return gap: ROIC of 7.0% against a WACC of 9.1% means growth adds less value than the capital it consumes. Net debt to EBITDA of 3.2 and interest coverage of 3.3 leave limited room if earnings fall further. Five-year revenue and EPS declines would need to reverse for the reverse DCF's 11.6% implied growth to be credible. The Beneish M-score is not available. The analysis has no debt maturity schedule and no revenue breakdown by segment or region, so refinancing timing and the source of growth cannot be checked. The Altman Z-score does not fit a consumer goods company well. The fair value band and the DCF rest on fixed assumptions, including a 5% equity risk premium and capped growth.
Metrics
Company
| Name | Estee Lauder Companies Inc |
|---|---|
| Sector | Consumer Defensive |
| Symbol | EL.US |
| Country | USA |
| Currency | USD |
| Industry | Household & Personal Products |
| Description | The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. The company provides skin care products, including moisturizers, serums, cleansers, toners, eye care, body care, exfoliators, acne care and oil correctors, facial masks, and sun care products; and makeup products, such as foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, mascaras, and eyeshadows and eyeliners, as well as compacts, brushes, and other makeup tools. It also offers fragrance products in various forms comprising parfum, eau de parfum, eau de toilette, eau de cologne, and body spray, as well as lotions, creams, powders, candles and soaps; and hair care products, including shampoos, conditioners, styling products, treatment, finishing sprays, and hair color products, as well as sells ancillary products and services. The company provides its products under the La Mer, Jo Malone London, TOM FORD, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, KILIAN PARIS, BALMAIN Beauty, Estée Lauder, Clinique, M·A·C, The Ordinary, Aveda, Bobbi Brown Cosmetics, Too Faced, Dr.Jart+, Bumble and bumble, Smashbox, Darphin Paris, Lab Series, Avestan, Loopha, Origins, NIOD, Aramis, and GLAMGLOW brands. It sells its products through department stores, duty-free retailers, specialty multi retailers, online pure players, upscale perfumeries and pharmacies, and top-tier salons and spas, as well as direct-to-consum |
| Fiscal year end | June |
Data dates
| Price | 2026-11-09 |
|---|---|
| Statements | 2026-09-30 |
| Risk free date | 2026-11-09 |
| Fundamentals fetched at | 2026-11-09T03:32:23.476Z |
Market
| Beta | 1.23 |
|---|---|
| Price | 113.16 |
| Market cap | 28,043,663,807 |
| Quote unit | USD |
| Shares now | 247,823,116 |
| Risk free rate | 0.0489 |
| Risk free symbol | US10Y |
| Enterprise value | 34,045,663,807 |
Financial health
| Altman z | 2.8983GREY |
|---|---|
| Quick ratio | 0.8173 |
| Current ratio | 1.2508OK |
| Debt to equity | 2.2784 |
| Net debt to ebitda | 3.2079WATCH |
| Interest coverage | 3.2749WATCH |
| Debt vs revenue growth5y | 0.0417 |
Earnings quality
| Beneish › M | — |
|---|---|
| Beneish › Label | — |
| Piotroski › Score | 7 |
| Piotroski › Passed | 7 |
| Piotroski › Evaluable | 9 |
| Fcf after sbc | 1,225,000,000 |
| Accrual ratio | -0.0802 |
| Sbc to revenue | 0.0191 |
| Fcf conversion5y | 1.3647 |
| Fcf conversion ttm | 4.1223 |
| Share count cagr5y | -0.0019 |
| Earnings surprises › Beats | 8 |
| Earnings surprises › Misses | 0 |
| Earnings surprises › Quarters | 8 |
| Earnings surprises › Average surprise pct | 49.6833 |
| Estimate revisions › Next year › Growth | 0.1852 |
| Estimate revisions › Next year › Change90d | 0.0604 |
| Estimate revisions › Next year › Up last30d | 6 |
| Estimate revisions › Next year › Down last30d | 4 |
| Estimate revisions › Current year › Change90d | 0.075 |
| Estimate revisions › Current year › Up last30d | 7 |
| Estimate revisions › Current year › Down last30d | 5 |
Profitability
| Roic | 0.0702 |
|---|---|
| Wacc | 0.091 |
| Dupont › As of | 2026-06-30 |
| Dupont › Net margin | 0.0121 |
| Dupont › Asset turnover | 0.7615 |
| Dupont › Equity multiplier | 5.1923 |
| Tax rate | 0.35 |
| Net margin | 0.0241 |
| Cost of debt | 0.0489 |
| Gross margin | 0.7604 |
| Cost of equity | 0.1105 |
| Roic median5y | 0.0636 |
| Roic minus wacc | -0.0208DESTROYS_VALUE |
| Return on equity | 0.0911 |
| Net margin median | 0.0721 |
| Operating margin | 0.1195 |
| Gross margin median | 0.7561 |
| Operating margin median | 0.1278 |
| Operating margin stability | 0.375 |
Growth
| Eps › Cagr3y | -0.4364 |
|---|---|
| Eps › Cagr5y | -0.4229 |
| Eps › Cagr10y | -0.1631 |
| Revenue › Cagr3y | -0.0184 |
| Revenue › Cagr5y | -0.0148 |
| Revenue › Cagr10y | 0.0294 |
| Fcf per share › Cagr3y | — |
| Fcf per share › Cagr5y | -0.15 |
| Fcf per share › Cagr10y | 0.0073 |
| Revenue growth consistency › Growing years | 6 |
| Revenue growth consistency › Comparable years | 10 |
Valuation
| Dcf › G1 | 0.0294 |
|---|---|
| Dcf › G t | 0.025 |
| Dcf › Fcf0 | 1,225,000,000 |
| Dcf › Discount rate | 0.1105 |
| Dcf › Terminal share | 0.4518 |
| Dcf › Fair value per share | 60.7199 |
| Current › Pb | 6.9449 |
| Current › Pe | 76.2056 |
| Current › Ps | 1.835 |
| Current › P fcf | 18.4863 |
| Current › Fcf yield | 0.0541 |
| Current › Ev to ebitda | 18.1965 |
| Current › Earnings yield | 0.0131 |
| Verdict | FAIR |
| Fair value › Low | 92.6946 |
| Fair value › Mid | 115.8683 |
| Fair value › High | 139.0419 |
| Fair value › Margin of safety | 0.0239 |
| Historical › Pb › Median | 10.4958 |
| Historical › Pb › Points | 10 |
| Historical › Pb › Current | 6.9449 |
| Historical › Pb › Premium pct | -0.3383 |
| Historical › Pe › Median | 45.9758 |
| Historical › Pe › Points | 9 |
| Historical › Pe › Current | 76.2056 |
| Historical › Pe › Premium pct | 0.6575 |
| Historical › Ps › Median | 3.6386 |
| Historical › Ps › Points | 10 |
| Historical › Ps › Current | 1.835 |
| Historical › Ps › Premium pct | -0.4957 |
| Historical › P fcf › Median | 41.1869 |
| Historical › P fcf › Points | 9 |
| Historical › P fcf › Current | 18.4863 |
| Historical › P fcf › Premium pct | -0.5512 |
| Historical › Ev to ebitda › Median | 25.3911 |
| Historical › Ev to ebitda › Points | 10 |
| Historical › Ev to ebitda › Current | 18.1965 |
| Historical › Ev to ebitda › Premium pct | -0.2834 |
| Reverse dcf › Implied growth | 0.1162 |
| Reverse dcf › Vs revenue cagr5y | 0.131 |
| Reverse dcf › Vs fcf per share cagr5y | 0.2662 |
| Historical fair value | 171.0167 |
Dividend
| Yield | 0.0181 |
|---|---|
| Payout on fcf | 0.3342 |
| Forward yield | 0.0127 |
Data flags
| Prices stale | No |
|---|---|
| Risk free stale | No |
| Fundamentals stale | No |


